Seer, Inc. (NASDAQ:SEER) Sees Significant Decrease in Short Interest

Seer, Inc. (NASDAQ:SEER) saw a large decrease in short interest in May. As of May 29th, there was short interest totaling 293,816 shares, a decrease of 35.1% from the May 14th total of 453,019 shares. Currently, 0.6% of the company’s stock are sold short. Based on an average trading volume of 287,229 shares, the days-to-cover ratio is currently 1.0 days.

Analysts Set New Price Targets

A number of brokerages have recently commented on SEER. Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a report on Tuesday, April 21st. TD Cowen raised Seer to a “strong-buy” rating in a report on Monday, April 13th. Finally, Canaccord Genuity Group assumed coverage on Seer in a report on Monday, May 4th. They set a “buy” rating and a $4.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Seer currently has a consensus rating of “Buy” and a consensus price target of $4.00.

Seer Trading Up 1.5%

SEER traded up $0.03 on Tuesday, hitting $1.74. 85,627 shares of the stock traded hands, compared to its average volume of 308,082. The business has a fifty day moving average price of $1.83 and a two-hundred day moving average price of $1.84. The firm has a market capitalization of $95.39 million, a PE ratio of -1.40 and a beta of 1.60. Seer has a 52 week low of $1.65 and a 52 week high of $2.41.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.30) EPS for the quarter, hitting analysts’ consensus estimates of ($0.30). The company had revenue of $2.79 million during the quarter, compared to the consensus estimate of $3.60 million. Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%.

Institutional Trading of Seer

A number of institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP increased its holdings in Seer by 2.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 235,485 shares of the company’s stock valued at $431,000 after buying an additional 6,304 shares during the period. Shay Capital LLC lifted its holdings in shares of Seer by 17.7% during the 3rd quarter. Shay Capital LLC now owns 73,571 shares of the company’s stock worth $160,000 after acquiring an additional 11,073 shares during the period. Occudo Quantitative Strategies LP bought a new stake in shares of Seer during the 2nd quarter worth approximately $25,000. Vanguard Group Inc. lifted its holdings in shares of Seer by 0.9% during the 3rd quarter. Vanguard Group Inc. now owns 2,221,404 shares of the company’s stock worth $4,820,000 after acquiring an additional 18,760 shares during the period. Finally, Corient Private Wealth LLC lifted its holdings in shares of Seer by 46.3% during the 2nd quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock worth $135,000 after acquiring an additional 20,000 shares during the period. Institutional investors own 75.20% of the company’s stock.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.